美国制药行业研究报告2009年10月

相似文件 换一批

是 否 +2 论坛币

k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群

赵安豆老师微信：zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

立即领取

感谢您参与论坛问题回答

经管之家送您两个论坛币！

+2 论坛币

Powerful Valuation Argument Outweighs Mixed Fundamental
Picture
Positive Factors ......................................................................................... 5
Neutral Factors... .................................................................................... 10
Negative Factors... .................................................................................. 16
Appendix: Tables Of Industry Fundamentals .......................................... 23
Company Discussions
AstraZeneca ................................................................................................... 27
Bristol-Myers Squibb ...................................................................................... 79
Eli Lilly ........................................................................................................ 121
GlaxoSmithKline........................................................................................... 171
Merck........................................................................................................... 223
Novartis ....................................................................................................... 275
Pfizer ........................................................................................................... 329
SanofiAventis ............................................................................................... 381
Schering-Plough ........................................................................................... 427
Wyeth .......................................................................................................... 467

扫码加我 拉你入群

请注明：姓名-公司-职位

以便审核进群资格，未注明则拒绝

分享0 收藏0 回帖

关键词：行业研究报告 制药行业 研究报告 行业研究 Fundamentals 美国 研究报告 行业